Marker-based CRISPR screens in pancreatic cancer cells followed by functional validation highlight a role for MED12 in bridging ΔNp63 and components of the Mediator family. This interaction helps drive basal cell identity in pancreatic ductal adenocarcinoma.
- Diogo Maia-Silva
- Patrick J. Cunniff
- Christopher R. Vakoc